Publications
Publications
Show Results For
- All HBS Web
(1,193)
- Faculty Publications (274)
- April 2003 (Revised December 2010)
- Case
Leadership in Crisis: Ernest Shackleton and the Epic Voyage of the Endurance
By: Nancy F. Koehn, Erica Helms and Philip Mead
Provides an opportunity to examine leadership and entrepreneurship in the context of Ernest Shackleton's 1914 Antarctic expedition, a compelling story of crisis, survival, and triumph. Summarizes Shackleton's career as an officer in the British Merchant Marine, his... View Details
- December 2002
- Teaching Note
Abgenix and the XenoMouse (TN)
Teaching Note for (501-061). View Details
- July 2002 (Revised August 2003)
- Case
Unilever Superannuation Fund vs. Merrill Lynch, The
By: Andre F. Perold and Joshua Musher
In 2001, the Unilever Superannuation Fund sued Merrill Lynch for damages of 130 million British pounds. Over the period 1977 to 1998, the Unilever Fund had significantly underperformed the benchmark, and its trustees contended that the poor returns resulted from... View Details
- June 2002
- Background Note
Note on the Value of Life
By: Michael A. Wheeler and Carlos Gonzalez
This case summarizes how American courts measure damages in wrongful death suits. Various standards are compared, as are their implications for business management. View Details
- October 2001 (Revised December 2001)
- Background Note
Extraterritorial Applications of Antitrust Law: U.S. and Japanese Approaches
By: Guhan Subramanian and Michelle Kalka
This case describes the differebt approaches the United States and Japan have taken to extend the jurisdiction of their antitrust laws to foreign companies. The section on the United States, in particular, focuses on the evolving logic of the Supreme Court in dealing... View Details
- January 2001
- Case
Abgenix and the XenoMouse
By: Robert J. Dolan
Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to... View Details
- February 2000 (Revised October 2000)
- Case
Kendle International Inc.
By: Dwight B. Crane, Paul W. Marshall and Indra Reinbergs
Candace Kendle and Christopher Bergen, the CEO and COO of Kendle International, Inc., are reviewing ways to finance the growth of their privately-owned company. Kendle is a contract research organization that conducts clinical drug trials for pharmaceutical and... View Details
- May 1999 (Revised July 2000)
- Teaching Note
Reading Rehabilitation Hospital: Implementing Patient-Focused Care TN
By: Jody H. Gittell and Sandra J. Sucher
Teaching Note for (9-898-172). A rewritten version of an earlier teaching note. View Details
- May 1999
- Case
The Saga of Prince Jefri and KPMG (A): Mystery of the Missing Billions
By: Ashish Nanda
Accounting and law firms around the globe are following with great interest the progress through British courts of a lawsuit. Those familiar with the suit, filed by Prince Jefri of Brunei against the professional service firm KPMG Peat Marwick, remark that its judgment... View Details
- February 1999 (Revised October 2009)
- Case
Royal Dutch/Shell in Nigeria (A)
By: Lynn S. Paine and Mihnea C. Moldoveanu
Working with Shell's country manager for Nigeria, the company's Committee of Managing Directors must decide how to respond to the Nigerian government's decision to impose the death sentence on Ken Saro-Wiwa and eight other leaders of a movement for the rights of the... View Details
- July 1998
- Supplement
Bell Atlantic in Union City
In this pioneering project to wire a school for the Internet and put computers in students' homes, Bell Atlantic combined its need for a beta site for a technology trial with the school reform efforts of the Union City, New Jersey public schools, under the leadership... View Details
- Article
Hype and Suspicion: The Effects of Pretrial Publicity, Race, and Suspicion on Jurors' Verdicts.
By: Steven Fein, Seth J. Morgan, Michael I. Norton and Samuel R. Sommers
- September 1997 (Revised August 2007)
- Case
Bankruptcy and Restructuring at Marvel Entertainment Group
By: Benjamin C. Esty and Jason Auerbach
Marvel Entertainment Group is the leading comic book publisher in the United States, with superheros like Spider-Man, the Incredible Hulk, the X-Men, and Captain America. It is also one of the leading manufacturers of sports and entertainment trading cards under the... View Details
- August 1997 (Revised July 1999)
- Case
Hewlett-Packard's Santa Rosa Systems Division (A): The Trials and Tribulations of a Legacy
By: Michael Beer
Describes the process of transforming a recently formed division of Hewlett-Packard. View Details
- 1996
- Chapter
The Determinants of Research Productivity in Ethical Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
- November 1994 (Revised December 1995)
- Case
Scripps Research Institute, The: November 1993 (Abridged)
By: Josh Lerner
In November 1993, Dr. Richard Lerner, president of the Scripps Research Institute, faces the challenge of maintaining his organization's financial and scientific vitality. A proposed cooperative venture with Sandoz has attracted considerable criticism. Meanwhile, a new... View Details
- September 1993 (Revised March 1997)
- Case
Lucas vs. South Carolina Coastal Council (A)
- April 1993 (Revised November 1994)
- Case
Chiron Corp.
Pablo Valenzuela, vice president of R&D at Chiron Corp., faces several choices for how to allocate scarce resources across several promising projects. These choices will determine Chiron's position in several emerging biotechnology and diagnostic markets, including... View Details
- November 1991 (Revised April 1994)
- Case
Nucleon, Inc.
By: Gary P. Pisano
Nucleon is a small biotechnology company whose first potential product is about to enter clinical testing. Before Nucleon can begin clinical trials, however, its management must decide how and where to manufacture the product. Three options are being contemplated: 1)... View Details